How Scientists Create Gametes from Stem Cells:Imagine a future where infertility is obsolete. A future where a same-sex couple can have a child genetically related to both parents, or where a cancer survivor can become a biological parent without worrying about frozen tissue. This is not science fiction. This is in vitro gametogenesis (IVG) , and it is reshaping reproductive biotechnology.
At the heart of this revolution lies a simple yet profound question: How scientists create gametes from stem cells? The answer involves coaxing ordinary skin or blood cells backward in time—turning them into primordial soup capable of building eggs and sperm from scratch.
We will dissect the step-by-step biology, explore the landmark breakthroughs in stem cell fertility research, and separate the hype from the reality of lab-grown sperm and lab-grown eggs.
How scientists create gametes from stem cells using IVG technology. A deep dive into lab-grown eggs, sperm, and the future of fertility.
What Are Gametes and Why Are They Important?
Before diving into the lab process, we need to understand the target.
- Gametes are the body’s reproductive cells: sperm in males and eggs (oocytes) in females. Unlike regular body cells (somatic cells), which contain 46 chromosomes (diploid), gametes contain only 23 chromosomes (haploid). When they fuse during fertilization, the resulting embryo restores the full genetic set.
For decades, the medical community assumed that the supply of gametes was finite. Women are born with all the eggs they will ever have; men produce sperm throughout life, but quality declines with age. Artificial gametes change this equation entirely. By manufacturing them in a dish, scientists can bypass biological clocks, damaged gonads, or missing reproductive organs.
What Are Stem Cells? The Raw Material
To understand IVG technology, you must understand stem cells. Think of stem cells as the “clay” of the body—unspecialized cells that can become almost anything.
There are two primary types used in this research:
Embryonic Stem Cells (ESCs)
Derived from early-stage embryos (blastocysts), ESCs are pluripotent, meaning they can form any cell type in the body, including gametes. However, their use is ethically contested because it involves embryo destruction.
Induced Pluripotent Stem Cells (iPSCs)
In 2006, Dr. Shinya Yamanaka (Nobel Prize, 2012) discovered that adult skin or blood cells could be “reprogrammed” back into an embryonic-like state using just four genetic factors (Oct4, Sox2, Klf4, c-Myc). These iPSCs avoid embryo destruction and are genetically matched to the donor. Today, most research on how scientists create gametes from stem cells uses iPSCs.
What Is In Vitro Gametogenesis (IVG)?
In vitro gametogenesis is the process of deriving functional eggs and sperm from pluripotent stem cells entirely outside the human body. If IVF (in vitro fertilization) is “helping sperm meet egg in a dish,” then IVG is “building the sperm and egg from scratch in a dish.”
Why is this significant?
- For infertile patients: Those with azoospermia (no sperm) or premature ovarian insufficiency.
- For cancer survivors: If radiation destroyed gonads, IVG offers a post-recovery path.
- For genetic preservation: No need to freeze eggs or sperm; freeze a skin sample instead.
- For same-sex couples: Two men could have a child using one man’s skin to make an egg; two women could make sperm (though Y-chromosome engineering remains complex).
Step-by-Step: How Scientists Create Gametes from Stem Cells
Here is the laboratory roadmap, simplified.
Step 1: Reprogramming Adult Cells into iPSCs
A scientist takes a small skin biopsy (fibroblasts) or a blood sample. Using viral or non-viral delivery of Yamanaka factors, they rewind the cells’ epigenetic clock. Over 3–4 weeks, the cells lose their identity and become induced pluripotent stem cells.
- Analogy: This is like taking a fully built car (skin cell) and melting it back into raw steel and rubber (stem cell).
Step 2: Differentiation into Primordial Germ Cell-Like Cells (PGCLCs)
The iPSCs are then guided toward the germline—the lineage that produces eggs and sperm. Researchers add specific growth factors (e.g., BMP4, WNT3a, and activin A) in precise timelines.
Within 4–5 days, the cells begin expressing key germ cell markers (e.g., BLIMP1, PRDM14, TFAP2C). These are now primordial germ cell-like cells—the embryonic precursors of gametes.
Step 3: Maturation into Sperm or Egg Cells
This is the hardest part. PGCLCs must undergo meiosis, the specialized cell division that halves chromosome number.
- For sperm (spermatogenesis): PGCLCs are co-cultured with testicular somatic cells (or organoids) and exposed to testosterone and retinoic acid. In mice, this yields swimming sperm with proper DNA methylation.
- For eggs (oogenesis): PGCLCs are aggregated with ovarian granulosa cells to form artificial ovarian follicles. They undergo a prolonged growth phase, then resume meiosis to produce mature, fertilizable eggs.
- Key signaling pathways involved: PI3K/AKT (follicle development), MAPK/ERK (meiotic resumption), and retinoic acid signaling (sex differentiation).
Step 4: Fertilization and Embryo Transfer
Once mature, the lab-grown eggs or lab-grown sperm are used in standard IVF. The resulting embryos are transferred to a uterus (in animal models) or frozen.
Major Scientific Breakthroughs and Studies
Mouse Model Successes (The Proof of Concept)
- 2011: Dr. Mitinori Saitou’s team (Kyoto University) produced fertile mouse eggs entirely from iPSCs. Those eggs gave rise to live, healthy pups.
- 2016: The same group generated functional mouse sperm from iPSCs.
- Today: Over 100 healthy, fertile mice have been born via IVG. They live normal lifespans, though some epigenetic abnormalities (imprinting defects) occur at low rates.
Human Research Progress (The Frontier)
- Human IVG is far behind mouse IVG for two reasons: longer developmental timelines (9 months vs. 3 weeks) and strict ethical regulations (14-day embryo culture rule).
Key milestones:
- 2018: Saitou’s team created human PGCLCs from iPSCs, but they stopped short of making mature eggs or sperm.
- 2022: Researchers in Israel and the UK successfully matured human PGCLCs to early meiosis (prophase I) in a testis organoid system.
- 2024 (latest): A biotech startup (Conception Biosciences) reported generating human spermatid-like cells (immature sperm) from XY iPSCs, though fertilization ability has not been proven.
No human baby has yet been born from lab-grown gametes. Experts estimate clinical availability is 10–20 years away.
Applications in Fertility Treatment
Helping Infertile Couples
Approximately 15% of couples globally face infertility. For those with non-obstructive azoospermia (no sperm in ejaculate) or primary ovarian insufficiency (menopause before 40), IVG could be the only path to a genetically related child.
Same-Sex Reproduction
- Two men: One man’s iPSCs could, in theory, be converted into an egg. But because male cells carry XY chromosomes, scientists must delete the Y and duplicate the X—a technically daunting but not impossible genetic engineering task.
- Two women: Easier. One woman’s iPSCs (XX) can be differentiated into sperm, but the resulting sperm would lack the Y chromosome and thus always produce female (XX) offspring.
Delayed Parenthood & Age Reversal
Egg quality declines steeply after age 35. Lab-grown eggs derived from a 50-year-old woman’s iPSCs would theoretically have “reset” epigenetic age—though nuclear DNA mutations remain.
Ethical, Legal, and Social Implications
This technology is a lightning rod for debate.
- The “Embryo Farming” Fear: Could a rogue lab generate thousands of embryos from a single skin sample for research or surrogacy? Regulations (e.g., the 14-day rule) are currently voluntary in many countries.
- Designer Babies: If we can make gametes, we can theoretically edit them (via CRISPR) before fertilization. This blurs the line between therapy and enhancement.
- Parental Age Evasion: Should an 80-year-old be allowed to produce a biologically related child via IVG? Biological aging may still imprint the epigenome.
- Cost & Access: Early IVG will be prohibitively expensive, potentially creating a fertility caste system.
- Expert opinion: Dr. Eli Adashi (Brown University) argues that “IVG is inevitable, but society needs a Geneva Convention for reproductive technology before it arrives.”
Risks and Challenges (The Scientific Reality)
Despite the hype, major hurdles remain.
| Challenge | Description |
| Genetic stability | iPSCs accumulate mitochondrial DNA mutations and copy-number variants during reprogramming. |
| Imprinting errors | Lab-grown gametes often fail to reset genomic imprints (methylation patterns), leading to syndromes like Beckwith-Wiedemann or Angelman. |
| Meiotic failure | Human meiosis is notoriously fragile; 90%+ of human PGCLCs fail to complete proper chromosome segregation in current protocols. |
| Safety | No long-term cancer risk data exists. If a partially reprogrammed cell is used, teratomas (tumors with hair/teeth) could form. |
The Future of Artificial Gametes
Where are we headed by 2035–2040?
- Clinical trials in Japan (regulatory framework is more permissive) for XY male infertility using IVG-derived spermatids.
- Commercial “gamete banks” where you deposit a skin sample instead of freezing eggs/sperm.
- Artificial ovaries/testes on chips – microfluidic devices that automate the entire IVG process.
- Solo reproduction – a single person providing both egg and sperm (isogenic embryos), though with extreme health risks due to recessive mutations.
FAQs
Can humans reproduce using lab-grown sperm today?
No. As of 2026, no human has been conceived using fully lab-grown sperm or eggs. Mouse models are successful, but human cells require much longer maturation and have failed to complete meiosis reliably. The closest progress is spermatid-like cells that have not been proven fertile.
Are artificial gametes safe?
Not yet. The primary safety concerns are epigenetic imprinting errors (which can cause developmental disorders) and the potential for cancerous transformation of iPSCs. Extensive animal safety studies—likely 10+ years—are required before human trials.
When will IVG be available clinically?
Most experts predict 2035–2045 for the first regulated clinical application in specific male infertility cases. Widespread use for same-sex couples or solo reproduction is likely 20–30 years away, assuming ethical and safety hurdles are cleared.
Can two men have a biological child using IVG?
Theoretically, yes. One man’s skin cells could be reprogrammed to iPSCs, then differentiated into an egg. However, the Y chromosome must be removed or inactivated, and an X chromosome duplicated. This has been done in mice, but not yet in humans. The resulting child would always be female (XX) unless a donor Y is introduced.
Do lab-grown gametes age the parent?
Lab-grown eggs and sperm show “reset” epigenetic clocks, meaning they resemble young gametes. However, the donor’s nuclear DNA still carries the mutations accumulated over a lifetime. There is no evidence of accelerated aging in offspring from animal studies, but long-term multigenerational studies are lacking.
A Revolution on Hold
The science of how scientists create gametes from stem cells has advanced from fantasy to mouse-proven reality in just two decades. We now have a roadmap: take skin, rewind to iPSCs, nudge toward PGCLCs, and carefully orchestrate meiosis.
But in vitro gametogenesis is not yet ready for the clinic. The gap between a mouse and a human is vast—especially in reproductive biology. Epigenetic fidelity, meiotic stability, and safety regulations form a formidable barrier.
Nevertheless, for the millions facing infertility, for the cancer survivor who did not freeze tissue, for the same-sex couple dreaming of a shared genetic legacy—the promise of lab-grown eggs and lab-grown sperm remains a beacon.
Stay informed. Follow Us And if you are considering fertility preservation today, remember: freezing skin is cheap; freezing eggs is invasive. The future might just need a tiny biopsy.